Patent · US Expired

Modified hemoglobin-like compounds

US5844090A · kind A · utility

9Cited by
12References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 1995
Grant dateDec 1, 1998
Priority date
Expiry dateJun 7, 2015

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/829
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to modified hemoglobin-like compounds. The novel compounds include a globin-like polypeptide containing at least two di-alpha domains and multimeric hemoglobin-like proteins having a core hemoglobin-like moiety directly attached to at least two other hemoglobin-like moieties. The invention also relates to nucleic acid molecules encoding the novel polypeptides. Methods of making the multimeric hemoglobin-like proteins are also provided, as well as compositions containing the proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.